A researcher in a mid-sized Indian medical college has one grant proposal on tuberculosis drug resistance. To fund it, she has to separately approach ICMR for scientific clearance, the Department of Health Research for institutional backing and her state health department for local implementation support - three different agencies, three different timelines, one unfunded idea.

The Policy Isn't About Money

• It's About Who Decides The target here isn't funding. It's coordination. The Draft National Health Research Policy 2026 states plainly that administrative and regulatory delays continue to slow down research even when funding is not the constraint. That single line reframes the entire story: India's problem in health research has never mainly been scarcity of money - it has been the absence of one body with the authority to say which disease gets studied first and by whom. Where the Chain Actually Breaks India runs health research through a genuinely crowded field - ICMR conducts and coordinates biomedical research, the Department of Health Research sits above it as the nodal department, individual state health departments run their own programmes and universities and medical colleges pursue research independently, often with no shared priority list. The result, as the draft policy itself notes, is that scientific capability remains concentrated in a handful of institutions and states, while research priorities frequently drift away from the country's actual disease burden, equity concerns and pandemic preparedness needs. This is not a funding gap. It is a coordination gap - multiple agencies each capable of approving or blocking a research proposal, with no single body responsible for setting the priority list all of them work from. The draft policy's actual fix is structural, not financial: a three-tier system with the National Health Research Stewardship Committee at the top for strategic coordination, the Department of Health Research as the implementing nodal agency beneath it and the ICMR retained as scientific and technical lead. For the first time, one body - the Stewardship Committee - is meant to periodically set a national research agenda based on disease burden, equity and pandemic preparedness, rather than leaving each institution and state to set its own. What This Doesn't Yet Fix The policy is still a draft, open for stakeholder feedback and it doesn't specify what happens when a state health department's priorities diverge from the national Stewardship Committee's agenda - the exact scenario that has historically produced regional research disparities in the first place. Coordination on paper is not coordination in a sanctioning process; the real test will be whether the Stewardship Committee is given actual authority to align state-level and institutional funding decisions or whether it becomes one more advisory layer sitting above an already fragmented system. For the exam, the useful distinction to carry forward is this: don't read this policy as "India investing more in health research." Read it as India attempting, for the first time, to answer a governance question it has never formally settled - who has the authority to decide which disease India studies first and can that authority actually bind the agencies below it.